Insider Transactions Reported by 25 Insiders of NovoCure Ltd

Symbol: NVCR on Nasdaq
Location: St. Helier

Quick Takeaways

NVCR - NovoCure Ltd has 25 insiders with reported activity on this page.
Net insider value flow over the last year: -$1,750,460.
Recent transaction rows are available for direct filing-level review.

What Changed

Buy value: $1,228,659; sell value: $2,979,118.
Net share flow: -109,911.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to selling over the last 12 months. Net value: -$1,750,460.

Buys

$1,228,659

Shares: 101,550

Insiders: 2

Sells

$2,979,119

Shares: 211,461

Insiders: 15

Net

-$1,750,460

Shares: -109,911

Insiders: -13

Window (months)	Buy shares	Sell shares	Buy $	Sell $	Net $
0-3	0	173,273	$0	$2,312,551	-$2,312,551
3-6	0	0	$0	$0	$0
6-9	81,550	0	$996,859	$0	+$996,859
9-12	20,000	38,188	$231,800	$666,568	-$434,768

NovoCure Ltd executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Valuation	Report Date
Ashley Cordova	Former Chief Executive Officer	$9,371,599	+$996,859	+12%	Mixed	04 Mar 2026
Frank X. Leonard	Chief Executive Officer	$8,052,580	-$833,601	-9.4%	Mixed	03 Mar 2026
Wilhelmus Cm Groenhuysen	Chief Operating Officer	$5,255,930			Mixed	28 Jun 2024
Uri Weinberg	Chf Medical and Innovation Ofr	$5,037,536	-$232,178	-4.4%	Mixed	03 Mar 2026
Asaf Danziger	Director	$4,577,049			Mixed	31 Dec 2025
Barak Ben Arye	General Counsel	$4,520,403			Mixed	03 Mar 2026
William F. Doyle	Executive Chairman, Director	$4,409,977	-$932,883	-17%	Filing P/S	03 Mar 2026
Michal Nath Puri	Chief Human Resources Officer	$4,161,136	-$34,325	-0.82%	Mixed	03 Mar 2026
Christoph Brackmann	Chief Financial Officer	$3,915,252	+$146,486	+3.9%	Mixed	03 Mar 2026
Nicolas Leupin	Former Chief Medical Officer	$2,852,643	-$28,696	-1%	Mixed	04 Mar 2026
Mukund Paravasthu	Chief Operating Officer	$2,485,654	-$693,966	-22%	Mixed	03 Mar 2026
Moshe Giladi	Chief Science Officer	$2,411,503			Mixed	27 Feb 2024
W. Anthony Vernon	Director	$2,288,094	-$17,329	-0.75%	Mixed	28 Apr 2026
Gabriel Leung	Director	$1,760,902	-$17,297	-0.97%	Mixed	04 Jun 2025
Shah Pritesh	Chief Growth Officer	$1,575,064			Filing P/S	07 Nov 2023
Todd Christopher Longsworth	General Counsel	$860,119			Mixed	08 Mar 2022
William Patrick Burke	Chief Human Resources Officer	$840,555			Mixed	30 Jun 2023
David Hung	Director	$521,742	-$17,280	-3.2%	Mixed	04 Jun 2025
Martin J. Madden	Director	$422,591	-$17,176	-3.9%	Mixed	04 Jun 2025
Timothy J. Scannell	Director	$410,865	-$17,299	-4%	Mixed	04 Jun 2025
Jeryl L. Hilleman	Director	$403,200	-$17,247	-4.1%	Mixed	04 Jun 2025
Ely Benaim	Chief Medical Officer	$363,941			Mixed	06 Jan 2023
Kristin Stafford	Director	$357,661	-$17,259	-4.6%	Mixed	04 Jun 2025
Allyson J. Ocean	Director	$357,661	-$17,269	-4.6%	Mixed	04 Jun 2025
Sherilyn S. McCoy	Director	$17,179			Mixed	09 Jun 2021

Top shareholders of NovoCure Ltd (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	15%	16,796,979	$217,184,938	—	31 Dec 2025	13F
BlackRock, Inc.	13F 13D/G	Company	8.3% from 13D/G	13,541,448	$175,090,922	—	31 Dec 2025	13F 13D/G
VANGUARD GROUP INC	13F	Company	9.6%	10,958,209	$141,689,643	—	31 Dec 2025	13F
Soleus Capital Master Fund, L.P.	13D/G	—	7.6%	8,530,665	$116,443,577	-$15,208,926	31 Dec 2025	13D/G
Soleus Capital Management, L.P.	13F	Company	7.5%	8,530,665	$110,301,498	—	31 Dec 2025	13F
VANGUARD PORTFOLIO MANAGEMENT LLC	13D/G	Vanguard Portfolio Management	5.6%	6,339,994	$69,105,935	$0	31 Mar 2026	13D/G
MORGAN STANLEY	13F	Company	4.5%	5,069,895	$65,553,743	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	2.3%	2,577,239	$33,323,700	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.2%	2,476,646	$32,028,911	—	31 Dec 2025	13F
Quantinno Capital Management LP	13F	Company	1.8%	2,010,248	$25,992,507	—	31 Dec 2025	13F
Capital World Investors	13D/G	—	1.8%	2,000,000	$25,840,000	-$56,626,396	30 Sep 2025	13D/G
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.2%	1,387,754	$17,943,659	—	31 Dec 2025	13F
Palo Alto Investors LP	13F	Company	1.1%	1,298,964	$16,795,605	—	31 Dec 2025	13F
Nuveen, LLC	13F	Company	1.1%	1,273,349	$16,464,403	—	31 Dec 2025	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	1.1%	1,223,755	$15,823,152	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	1%	1,178,045	$15,232,122	—	31 Dec 2025	13F
BAILLIE GIFFORD & CO	13F	Company	0.99%	1,121,274	$14,498,073	—	31 Dec 2025	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.9%	1,019,969	$13,483,990	—	31 Dec 2025	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.92%	1,041,532	$13,467,009	—	31 Dec 2025	13F
C WorldWide Group Holding A/S	13F	Company	0.85%	971,784	$12,565,000	—	31 Dec 2025	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.81%	927,400	$11,991,282	—	31 Dec 2025	13F
Point72 Asset Management, L.P.	13F	Company	0.79%	900,496	$11,643,413	—	31 Dec 2025	13F
ALGERT GLOBAL LLC	13F	Company	0.77%	878,998	$11,365,000	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.77%	876,816	$11,337,231	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.75%	858,986	$11,106,689	—	31 Dec 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	0.72%	822,385	$10,633,438	—	31 Dec 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.66%	752,143	$9,726,934	—	31 Dec 2025	13F
Ashley Cordova	3/4/5	Former Chief Executive Officer	— mixed-class rows	646,693 mixed-class rows	$9,371,599	+$996,859	04 Mar 2026	3/4/5
SILVERCREST ASSET MANAGEMENT GROUP LLC	13F	Company	0.62%	707,609	$9,149,384	—	31 Dec 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.59%	675,831	$8,738,495	—	31 Dec 2025	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.58%	661,297	$8,550,570	—	31 Dec 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.57%	646,666	$8,361,391	—	31 Dec 2025	13F
Frank X. Leonard	3/4/5	Chief Executive Officer	— mixed-class rows	791,680 mixed-class rows	$8,052,580	-$833,601	03 Mar 2026	3/4/5
Jump Financial, LLC	13F	Company	0.49%	561,237	$7,256,794	—	31 Dec 2025	13F
Vestal Point Capital, LP	13F	Company	0.46%	525,000	$6,788,250	—	31 Dec 2025	13F
BARCLAYS PLC	13F	Company	0.39%	447,255	$5,783,008	—	31 Dec 2025	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.36%	414,742	$5,362,614	—	31 Dec 2025	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.36%	407,204	$5,265,148	—	31 Dec 2025	13F
Legal & General Group Plc	13F	Company	0.36%	406,664	$5,258,165	—	31 Dec 2025	13F
Wilhelmus Cm Groenhuysen	3/4/5	Chief Operating Officer	— mixed-class rows	347,290 mixed-class rows	$5,255,930	—	28 Jun 2024	3/4/5
JPMORGAN CHASE & CO	13F	Company	0.35%	402,882	$5,209,264	—	31 Dec 2025	13F
Uri Weinberg	3/4/5	Chf Medical and Innovation Ofr	— mixed-class rows	422,029 mixed-class rows	$5,037,536	-$232,178	03 Mar 2026	3/4/5
IEQ CAPITAL, LLC	13F	Company	0.33%	378,974	$4,900,134	—	31 Dec 2025	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	0.33%	373,392	$4,828,000	—	31 Dec 2025	13F
Asaf Danziger	3/4/5	Director	0.37%	416,474	$4,577,049	—	31 Dec 2025	3/4/5
TWO SIGMA INVESTMENTS, LP	13F	Company	0.31%	352,459	$4,557,295	—	31 Dec 2025	13F
Barak Ben Arye	3/4/5	General Counsel	— mixed-class rows	397,292 mixed-class rows	$4,520,403	—	03 Mar 2026	3/4/5
BANK OF AMERICA CORP /DE/	13F	Company	0.3%	342,953	$4,434,381	—	31 Dec 2025	13F
William F. Doyle	3/4/5	Executive Chairman, Director	— mixed-class rows	616,914 mixed-class rows	$4,409,977	-$932,883	03 Mar 2026	3/4/5
Michal Nath Puri	3/4/5	Chief Human Resources Officer	— mixed-class rows	341,493 mixed-class rows	$4,161,136	-$34,325	03 Mar 2026	3/4/5

Recent Insider Transactions by Companies or Individuals for NovoCure Ltd

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
W. Anthony Vernon	NVCR	Ordinary Shares	Options Exercise	12%			21,500	200,602	28 Apr 2026	Direct
W. Anthony Vernon	NVCR	Stock Option (Right to Buy)	Options Exercise	-100%			-21,500	0	28 Apr 2026	Direct
Mukund Paravasthu	NVCR	Ordinary Shares	Sale	-37.3%	$595,670	$13.77	-43,246	72,832	05 Mar 2026	Direct
Nicolas Leupin	NVCR	Ordinary Shares	Sale	-1.06%	$14,636	$13.31	-1,100	102,979	04 Mar 2026	Direct
Ashley Cordova	NVCR	Ordinary Shares	Tax liability	-4.01%			-17,638	422,570	04 Mar 2026	Direct
Uri Weinberg	NVCR	Ordinary Shares	Sale	-2.34%	$85,314	$13.31	-6,412	267,190	04 Mar 2026	Direct
Christoph Brackmann	NVCR	Ordinary Shares	Sale	-3.39%	$85,314	$13.31	-6,412	182,842	04 Mar 2026	Direct
Frank X. Leonard	NVCR	Ordinary Shares	Sale	-1.12%	$74,603	$13.31	-5,607	493,793	04 Mar 2026	Direct
Mukund Paravasthu	NVCR	Ordinary Shares	Sale	-4.43%	$71,543	$13.31	-5,377	116,078	04 Mar 2026	Direct
Michal Nath Puri	NVCR	Ordinary Shares	Sale	-0.54%	$14,636	$13.31	-1,100	201,322	04 Mar 2026	Direct
Barak Ben Arye	NVCR	Ordinary Shares	Award	26.1%			50,125	242,453	03 Mar 2026	Direct
Barak Ben Arye	NVCR	Stock Option (Right to Buy)	Award				73,340	73,340	03 Mar 2026	Direct
Uri Weinberg	NVCR	Ordinary Shares	Award	22.4%			50,125	273,602	03 Mar 2026	Direct
Uri Weinberg	NVCR	Stock Option (Right to Buy)	Award				73,340	73,340	03 Mar 2026	Direct
Christoph Brackmann	NVCR	Ordinary Shares	Award	41.1%			55,137	189,254	03 Mar 2026	Direct
Christoph Brackmann	NVCR	Stock Option (Right to Buy)	Award				80,674	80,674	03 Mar 2026	Direct
Frank X. Leonard	NVCR	Ordinary Shares	Award	42.9%			150,000	499,400	03 Mar 2026	Direct
Frank X. Leonard	NVCR	Stock Option (Right to Buy)	Award				216,388	216,388	03 Mar 2026	Direct
Mukund Paravasthu	NVCR	Ordinary Shares	Award	59.1%			45,112	121,455	03 Mar 2026	Direct
Mukund Paravasthu	NVCR	Stock Option (Right to Buy)	Award				66,006	66,006	03 Mar 2026	Direct
Michal Nath Puri	NVCR	Ordinary Shares	Award	24.7%			40,100	202,422	03 Mar 2026	Direct
Michal Nath Puri	NVCR	Stock Option (Right to Buy)	Award				58,672	58,672	03 Mar 2026	Direct
William F. Doyle	NVCR	Ordinary Shares	Sale	-18%	$932,883	$12.98	-71,887	328,397	03 Mar 2026	Direct
William F. Doyle	NVCR	Ordinary Shares	Award				400,284	400,284	03 Mar 2026	Direct
William F. Doyle	NVCR	Stock Option (Right to Buy)	Award				288,517	288,517	03 Mar 2026	Direct
Mukund Paravasthu	NVCR	Ordinary Shares	Sale	-0.53%	$5,505	$13.49	-408	76,343	02 Mar 2026	Direct
Frank X. Leonard	NVCR	Ordinary Shares	Sale	-2.03%	$97,581	$13.49	-7,232	349,400	02 Mar 2026	Direct
Ashley Cordova	NVCR	Ordinary Shares	Tax liability	-2.14%			-9,638	440,208	02 Mar 2026	Direct
Uri Weinberg	NVCR	Ordinary Shares	Sale	-1.44%	$43,607	$13.33	-3,272	223,477	02 Mar 2026	Direct
Frank X. Leonard	NVCR	Ordinary Shares	Award	5.51%			18,621	356,632	28 Feb 2026	Direct
Ashley Cordova	NVCR	Ordinary Shares	Award	5.59%			23,818	449,846	28 Feb 2026	Direct
Uri Weinberg	NVCR	Ordinary Shares	Award	6.08%			12,992	226,749	28 Feb 2026	Direct
Barak Ben Arye	NVCR	Ordinary Shares	Award	10.2%			17,755	192,328	28 Feb 2026	Direct
Mukund Paravasthu	NVCR	Ordinary Shares	Sale	-1.99%	$21,247	$13.66	-1,555	76,751	27 Feb 2026	Direct
Nicolas Leupin	NVCR	Ordinary Shares	Sale	-0.98%	$14,060	$13.66	-1,029	104,079	27 Feb 2026	Direct
Michal Nath Puri	NVCR	Ordinary Shares	Sale	-0.88%	$19,690	$13.66	-1,441	162,322	27 Feb 2026	Direct
Frank X. Leonard	NVCR	Ordinary Shares	Sale	-2.8%	$133,003	$13.66	-9,734	338,011	27 Feb 2026	Direct
Ashley Cordova	NVCR	Ordinary Shares	Tax liability	-2.64%			-11,541	426,028	27 Feb 2026	Direct
Uri Weinberg	NVCR	Ordinary Shares	Sale	-3.37%	$103,257	$13.84	-7,461	213,757	27 Feb 2026	Direct
Mukund Paravasthu	NVCR	Ordinary Shares	Tax liability	-2.65%			-2,133	78,306	11 Jan 2026	Direct
Michal Nath Puri	NVCR	Ordinary Shares	Award				1	163,763	31 Dec 2025	Direct
Asaf Danziger	NVCR	Ordinary Shares	Award				1	416,474	31 Dec 2025	Direct
Barak Ben Arye	NVCR	Ordinary Shares	Award	0.06%			108	174,573	31 Dec 2025	Direct
Christoph Brackmann	NVCR	Ordinary Shares	Tax liability	-4.98%			-7,033	134,117	04 Nov 2025	Direct
Mukund Paravasthu	NVCR	Ordinary Shares	Tax liability	-3.54%			-2,949	80,439	04 Nov 2025	Direct
Mukund Paravasthu	NVCR	Ordinary Shares	Tax liability	-0.2%			-168	83,388	01 Nov 2025	Direct
Frank X. Leonard	NVCR	Ordinary Shares	Tax liability	-0.28%			-966	347,745	01 Nov 2025	Direct
Michal Nath Puri	NVCR	Ordinary Shares	Tax liability	-0.46%			-752	163,762	31 Oct 2025	Direct
Ashley Cordova	NVCR	Ordinary Shares	Purchase	22.9%	$996,859	$12.22	81,550	437,569	05 Sep 2025	Direct
Christoph Brackmann	NVCR	Ordinary Shares	Purchase	16.5%	$231,800	$11.59	20,000	141,150	29 Jul 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.